Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
about
Do mast cells link obesity and asthma?Biomarkers in the Management of Difficult AsthmaCD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse modelsMonoclonal antibodies and other biologic agents in the treatment of asthmaMontelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics.Does airway smooth muscle express an inflammatory phenotype in asthma?Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma.Current and future biomarkers in allergic asthma.Decrease in airway mucous gene expression caused by treatment with anti-tumor necrosis factor alpha in a murine model of allergic asthma.Mast cells in airway diseases and interstitial lung diseaseEffects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis.Targeting tumour necrosis factor-alpha in corticosteroid-dependent asthma.Etanercept for refractory asthma therapy.Targeted interventions for difficult-to-treat asthma.Asthma control, adiposity, and adipokines among inner-city adolescentsMacrophage heterogeneity in respiratory diseases.Targeting TNF-alpha: a novel therapeutic approach for asthmaUsing guinea pigs in studies relevant to asthma and COPD.TNF-308 modifies the effect of second-hand smoke on respiratory illness-related school absencesAssociation of insulin resistance with bronchial hyperreactivityTumor necrosis factor-alpha in severe corticosteroid-refractory asthma.Immunotherapy in asthma.Mast cells in allergic asthma and beyond.Involvement of TNFalpha -308A promoter polymorphism in the development of asthma in children infected with Chlamydophila pneumoniae.Airway smooth muscle and immunomodulation in acute exacerbations of airway disease.Targeting airway smooth muscle in airways diseases: an old concept with new twistsEosinophils and mast cells as therapeutic targets in pediatric functional dyspepsiaBiomarkers in the clinical development of asthma therapies.Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.Diallyl sulfide as a potential dietary agent to reduce TNF-α- and histamine-induced proinflammatory responses in A7r5 cells.Should treatments for asthma be aimed at the airway smooth muscle?Anti-TNFα therapy in inflammatory lung diseases.Modulation by flunisolide of tumor necrosis factor-alpha-induced stimulation of airway epithelial cell activities related to eosinophil inflammation.Novel anti-inflammatory treatments for asthma.Genetic factors in the treatment of bronchial asthma.Asthma: eosinophil disease, mast cell disease, or both?Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma.Conditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation.Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.Effect of tumor necrosis factor-α antagonism in asthma: a meta-analysis of the published literature.
P2860
Q27001152-CDC0F1E1-E938-40AA-8959-B9352F8F25BBQ28081109-F2E1DB50-35EE-4D7A-B5EF-ED95797083E6Q28087345-B3E2A06D-4663-4F92-AB7E-E9FC8A24A2DBQ28270037-EDEDA750-01A5-4D72-94AF-B2A6E9BCFE34Q33443525-52ED760E-1487-4DCF-93D5-8BE82A2E60C6Q34903113-072CE995-F54D-4998-B2A8-6A11B6FA3974Q35537338-FB20F949-5FC8-4633-B113-96089AF3DD68Q35878914-4372A102-DBC2-400D-B37F-3D9BB8973EE0Q36207811-414D105F-0585-4080-A47A-A65C37A4EA15Q36260500-EF2D362F-DEE1-4C2A-A1FD-56301AA40468Q36477126-AA7D8FAC-B9FB-4AF4-9ECD-7B056A0DBE3EQ36481084-630B8929-C6F7-4736-9CE0-AF6CBEA08E6FQ36600312-2C6CD55E-F589-4D07-80EF-A02777A62E4DQ36675485-7762F7FF-6E22-4AEB-99AC-AC079D5F93D0Q36682370-F6789889-C692-4856-B9A8-D73C11C12260Q36692041-97AF3776-F540-4239-AB72-0CE32395A4C3Q37013367-FEC11CB5-0B2B-4559-9173-81E6A7E09CB8Q37157003-33C838ED-3CD2-46A1-97ED-F2DB85D71BE2Q37282745-4D4D9AE8-CDA7-428E-B046-CDB84791F4F0Q37733676-6976D294-CE09-4872-9DEF-0DB2CD8978C2Q37754950-B942DF7D-6531-4768-90B7-B5F19DDD62B8Q37793242-62E134E0-80D8-4E64-B852-F77DD277F739Q37794115-1BC3435B-1FF2-417C-8A90-8F9185B72BEEQ37861417-FFB61D25-B931-4902-8832-CF34FB8CB2CCQ37891134-58D5BF58-DDCA-449B-A806-926FCD34457FQ37955927-EFF52F66-35A7-4A9C-A98A-59654AD8F0A3Q38160491-330382C9-0F66-447A-BBA7-12CF5F2B0868Q38695917-4B5A69EC-8644-43C7-BBEC-CA0DD1580751Q38915978-611ACDED-CD60-4916-82EF-51443787BFE5Q39035174-88143DFF-1E6D-448F-AE61-A66CB821A722Q39329760-C5D1A814-16F2-4C60-AAD9-E048D80C776CQ39392448-FC5CA71D-53C4-44F5-8379-C397B990ADBEQ39696203-D62E9259-BECB-4756-A809-DB42BC2E1495Q40041782-C219F166-C469-4CCE-AA96-0A8A91B5759EQ40292888-1FEF33C4-0240-44A5-8687-1DE65A3FF077Q40518724-D4407843-7D3D-4AD5-B69F-CA62CF166AE9Q41886208-08C9E9EC-8D7A-42C6-AEA1-2D583EA29C7DQ42106315-F62D0457-D244-4CD2-8726-52902715E03EQ42715351-82971EA1-0B0F-4011-96F0-382F78792A0CQ44202329-E5D98E70-B09A-430C-B6E7-4F95B9A01D92
P2860
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
@ast
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
@en
type
label
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
@ast
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
@en
prefLabel
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
@ast
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
@en
P2860
P356
P1433
P1476
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
@en
P2093
P2860
P304
P356
10.1136/THORAX.57.9.774
P407
P577
2002-09-01T00:00:00Z